Found 6 matching trials
Higher Infused Lymphocyte Counts Improve Antibody Response to Immunization After Autologous Stem Cell Transplantation
N/AThe purpose of this study is to determine if higher absolute lymphocyte cou...
Location
Dartmouth-Hitchcock Medical Center
High-dose Etoposide Could Discriminate Patients With Refractory/Relapsed Lymphoma Benefit From APBSCT
N/Apatients with refractory /relapsed lymphoma received high-dose etoposide fo...
Location
Multiple Locations
Trial for Patients With Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma
PHASE2This is a multicenter open label randomized phase II trial.
Enrolled Prima...
Location
University Hospital
Phase I Trial of Clofarabine in Combo w/ HD Etoposide & Cyclophosphamide and APBSCT for Pts w/ High-Risk or Refractory NHL
PHASE1This is a phase I trial to determine the maximum tolerated dose (MTD) of cl...
Location
Indiana University Cancer Center
A Phase II Study of Allo-HCT for B-Cell NHL Using Zevalin, Fludarabine and Melphalan
PHASE2RATIONALE: Giving monoclonal antibody therapy, radioimmunotherapy, and chem...
Location
City of Hope Medical Center
FM 140 vs FM100 Study in Patients With Multiple Myeloma
PHASE2The goal of this clinical research study is to learn if there is a differen...
Location
UT MD . Anderson Cancer Center